LA4489-6
Unknown
Active
Answer Lists using this Answer Code
Answer List | Answer List Name | Externally Defined |
---|---|---|
LL105-8 | CR_1480_Protocol source | N |
LL1052-1 | Injury intent | N |
LL1053-9 | ED dispo | N |
LL107-4 | CR_150_Marital status | N |
LL113-2 | CR_1550_Radiation treatment location | N |
LL114-0 | CR_1560_Radiation intent | N |
LL115-7 | CR_1570_Radiation modality | N |
LL117-3 | CR_1590_Radiation outcome | N |
LL118-1 | CR_160_Race | N |
LL119-9 | CR_161_Race2 | N |
LL124-9 | CR_1646_Surgery site | N |
LL1248-5 | PhenX11_10_glaucoma drops | N |
LL131-4 | CR_1770_Cancer status follow up | N |
LL133-0 | CR_1790_Follow up source | N |
LL1362-4 | PhenX12_83 | N |
LL146-2 | CR_190_Hispanic origin | N |
LL1557-9 | PhenX10_61 | N |
LL1633-8 | PhenX18_16_hip fracture location | N |
LL1634-6 | PhenX18_17_fracture treatment | N |
LL1635-3 | PhenX18_18_fracture circumstances | N |
LL1636-1 | PhenX18_19_trauma location | N |
LL1637-9 | PhenX18_20_time of fracture | N |
LL1638-7 | PhenX18_21_fracture circumstances | N |
LL1677-5 | PhenX19_23_CA histopathology type | N |
LL1678-3 | PhenX19_24_CA histopathology grade | N |
LL1735-1 | FeedingType | N |
LL179-3 | CR_2140_CoC coding system | N |
LL1823-5 | NEMSIS_36_pt loc in vehicle | N |
LL183-5 | CR_220_Sex-gender | N |
LL187-6 | CR_2320 | N |
LL1872-2 | FMQAI_01 | N |
LL1942-3 | Death certificate_tobacco use | N |
LL1959-7 | PhenX17_14_death in hospitalization | N |
LL204-9 | CR_3300_Rural-urban 1993 | N |
LL205-6 | CR_340_Tobacco history | N |
LL206-4 | CR_35_FIN coding system | N |
LL208-0 | CR_360_Fam hx of cancer | N |
LL218-9 | CR_490_Diagnostic confirmation | N |
LL2192-4 | RHEA - last born child vital status | N |
LL222-1 | CR_520_Screening result | N |
LL224-7 | CR_590_ Inpatient admit date | N |
LL225-4 | CR_600_Inpatient discharge date | N |
LL226-2 | CR_610_Hospital-cancer relationship | N |
LL227-0 | CR_670_Surgical protocol | N |
LL234-6 | CR_910_Tumor stage group | N |
LL235-3 | CR_920_Pathology descriptor | N |
LL241-1 | CR_980_Clincial staging descriptor | N |
LL2454-8 | 0| |
N |
LL247-8 | OASIS_M0140_Race-ethnicity | N |
LL248-6 | OASIS_M0150_Payment sources | N |
LL2511-5 | MD-DO-CNM/CM-Other Midwife-Other | N |
LL2513-1 | Type of place where birth occurred | N |
LL2517-2 | Cephalic-Breech-Other | N |
LL2518-0 | Route/method of delivery | N |
LL252-8 | OASIS_M0220_Prior condition | N |
LL2521-4 | First-Second-Third-Fourth-etc. | N |
LL2533-9 | Planned to deliver at home | N |
LL255-1 | OASIS_M0260_Prognosis for recovery | N |
LL256-9 | OASIS_M0270_Rehab prognosis | N |
LL258-5 | OASIS_M0290_High risk factors | N |
LL261-9 | OASIS_M0350_Assisting person | N |
LL262-7 | OASIS_M0360_Primary caregiver | N |
LL263-5 | OASIS_M0370_PCG assistance freq | N |
LL264-3 | OASIS_M0380_Assistance type | N |
LL2655-0 | AHRQ_Medication_Q2 | N |
LL2660-0 | AHRQ_Medication_Q7 | N |
LL2662-6 | AHRQ_Medication_Q9 | N |
LL2663-4 | AHRQ_Medication_Q10 | N |
LL2664-2 | AHRQ_Medication_Q11 | N |
LL2665-9 | AHRQ_Medication_Q12 | N |
LL2669-1 | AHRQ_Medication_Q16 | N |
LL2682-4 | AHRQ_Medication_Q28_Q29 | N |
LL276-7 | OASIS_M0510_UTI treatment | N |
LL279-1 | OASIS_M0540_Bowel incontinence freq | N |
LL2814-3 | AHRQ_PIF_1 | N |
LL2815-0 | AHRQ_PIF_2 | N |
LL2816-8 | AHRQ_PIF_3 | N |
LL2817-6 | AHRQ_Y/N/UNK | N |
LL2818-4 | AHRQ_PIF_6 | N |
LL2819-2 | AHRQ_PIF_7 | N |
LL2820-0 | AHRQ_PIF_8 | N |
LL2821-8 | AHRQ_PIF_9 | N |
LL2822-6 | AHRQ_PIF_10 | N |
LL2823-4 | AHRQ_PIF_11 | N |
LL2827-5 | AHRQ_M/F/UNK | N |
LL2829-1 | AHRQ_SIR_1 | N |
LL2830-9 | AHRQ_SIR_2 | N |
LL2833-3 | AHRQ_SIR_5 | N |
LL2837-4 | AHRQ_SIR_12 | N |
LL2838-2 | AHRQ_Device_1 | N |
LL2842-4 | AHRQ_Device_11 | N |
LL2843-2 | AHRQ_Device_12 | N |
LL2844-0 | AHRQ_Device_13 | N |
LL2858-0 | Race or Unknown | N |
LL288-2 | OASIS_M0640_Prior grooming | N |
LL290-8 | OASIS_M0650_Prior dress upper body | N |
LL292-4 | OASIS_M0660_Prior dress lower body | N |
LL2927-3 | CDC.CS_25_Vital status | N |
LL294-0 | OASIS_M0670_Prior bathing | N |
LL296-5 | OASIS_M0680_Prior toileting | N |
LL298-1 | OASIS_M0690_Prior transferring | N |
LL300-5 | OASIS_M0700_Prior ambulation | N |
LL3012-3 | PCORI_Information data source | N |
LL3017-2 | Discharge vital status | N |
LL3018-0 | MSCDM_Discharge status | N |
LL302-1 | OASIS_M0710_Prior feeding | N |
LL3031-3 | Patient Residence Type | N |
LL3034-7 | ED Episode Care | N |
LL304-7 | OASIS_M0720_Prior light meals | N |
LL3044-6 | Yes/No/Unk | N |
LL306-2 | OASIS_M0730_Priot transportation | N |
LL3068-5 | MSCDM_Admitting Source | N |
LL308-8 | OASIS_M0740_Prior laundry | N |
LL310-4 | OASIS_M0750_Prior housekeeping | N |
LL312-0 | OASIS_M0760_Prior shopping | N |
LL3134-5 | Cause Fetal Death | N |
LL314-6 | OASIS_M0770_Prior telephone use | N |
LL316-1 | OASIS_M0780_Prior oral med mgmnt | N |
LL318-7 | OASIS_M0790_Prior inhaled med mgmnt | N |
LL3188-1 | 20150106-APTASet1_11 | N |
LL320-3 | OASIS_M0800_Prior inject med mgmnt | N |
LL322-9 | OASIS_M0820_PCG equip mgmnt | N |
LL324-5 | OASIS_M0830_OP emergent care | N |
LL3275-6 | NMMDS_Gender | N |
LL329-4 | OASIS_M0890_Reason acute hospitalization | N |
LL331-0 | OASIS_M0900_Nursing home admission | N |
LL3323-4 | Sexual orientation | N |
LL3324-2 | Sex assigned at birth | N |
LL3638-5 | Heparin| |
N |
LL3639-3 | Positive| |
N |
LL3656-7 | [NHCS] Surgery 24H post-op follow-up outcomes | N |
LL3676-5 | [NHCS] Outpatient visit discharge disposition | N |
LL3722-7 | [NEI] Amblyopia type | N |
LL3723-5 | [NEI] Coloboma location | N |
LL3724-3 | [NEI] Color vision findings | N |
LL3725-0 | [NEI] Color vision test method | N |
LL3726-8 | Normal| |
N |
LL3727-6 | [NEI] Findings supporting myopathy | N |
LL3728-4 | [NEI] Type of congenital cranial dysinnervation (C | N |
LL3729-2 | [NEI] Gross eye defects | N |
LL3730-0 | [NEI] Eye-related MRI findings | N |
LL3732-6 | [NEI] International classification (ABC) of intra | N |
LL3733-4 | [NEI] International classification for extraocular | N |
LL3735-9 | [NEI] Corneal dystrophy type | N |
LL3736-7 | [NEI] Previous ophthalmologic treatment | N |
LL3739-1 | [NEI] Ophthalmologic disease related systemic find | N |
LL3740-9 | [NEI] Tetraparesis type | N |
LL3741-7 | [NEI] Tissue types positive for axonal spheroids | N |
LL3746-6 | [NEI] Whole mount exam findings | N |
LL3756-5 | [NEI] Ocular motility findings | N |
LL3761-5 | [NEI] Ocular fundus angiography findings | N |
LL3763-1 | [NEI] Optical coherent tomography (OCT) findings | N |
LL3771-4 | [NEI] Objective refraction method | N |
LL3788-8 | [NEI] Refraction method | N |
LL3792-0 | No| |
N |
LL3860-5 | DBS collection method | N |
LL3865-4 | True| |
N |
LL3870-4 | [NEI] Progression of problem | N |
LL3871-2 | [NEI] VEP result | N |
LL3872-0 | [NEI] Pigmentation | N |
LL3972-8 | NCHS_Tabulated Ethnicity Detail | N |
LL3991-8 | CDC_Transmission setting | N |
LL4025-4 | Allelic phase | N |
LL4052-8 | Prenatal test | |
N |
LL4064-3 | Gene sequencing | |
N |
LL4120-3 | PCORI_response_method | N |
LL4121-1 | PCORI_response_source | N |
LL4122-9 | yes| |
N |
LL4123-7 | PCORI_Smoked_v_non-smoked_tobacco | N |
LL4124-5 | Expedite| |
N |
LL4125-2 | Laboratory| |
N |
LL4126-0 | PCORI_Cause_of_death_rank | N |
LL4128-6 | Yes, specify | |
N |
LL4129-4 | Pregnant| |
N |
LL4139-3 | Confirmed| |
N |
LL4151-8 | CMS IRFPAI_GG0100 Prior Functioning | N |
LL4184-9 | No | |
N |
LL4207-8 | Imputed parts of DOD | N |
LL4208-6 | Excellent| |
N |
LL4309-2 | Independent | |
N |
LL4353-0 | Reason vaccine not received | N |
LL4354-8 | Antibody test results | N |
LL4356-3 | Relationships | N |
LL4359-7 | Susceptible| |
N |
LL4362-1 | Confirmed| |
N |
LL4363-9 | RV genotype | N |
LL4364-7 | Private sector| |
N |
LL4470-2 | CMS_LCDS Payer information | N |
LL4567-5 | Known| |
N |
LL4649-1 | Healthy| |
N |
LL4651-7 | No| |
N |
LL4652-5 | <3 meters | |
N |
LL4653-3 | Role of person in accident | N |
LL4656-6 | Minimal| |
N |
LL4729-1 | Current every day user | |
N |
LL486-2 | DEEDS4.08_1st Acuity Assessment | N |
LL4970-1 | CMS MDS Prior Functioning | N |
LL5029-5 | APTA_Payor type | N |
LL508-3 | HL79010_Med reason-unsched trip | N |
LL526-5 | DEEDS4.21_1st HR | N |
LL527-3 | DEEDS4.26_1st Temp | N |
LL528-1 | DEEDS4.29_Measured weight | N |
LL5313-3 | Intentional | |
N |
LL5315-8 | Monochorionic | |
N |
LL5318-2 | Never | |
N |
LL5338-0 | Highest Education Level | N |
LL5420-6 | CMS IRFPAI v4.0_GG0100 Prior Functioning | N |
LL544-8 | CARE_1_D_Payor Information | N |
LL545-5 | CARE_2_b01_Prior residence type | N |
LL5454-5 | CMS_MDS v1.18.1 - GG0100 | N |
LL546-3 | CARE_2_b05a_Prior Functioning | N |
LL548-9 | CARE_2_B3_Community assistance | N |
LL5489-1 | Origin of Genetic Variance | N |
LL549-7 | CARE_2_B3a_Living situation | N |
LL550-5 | CARE_2_B4_Structural barriers | N |
LL551-3 | CARE_2_B6_Mobility devices | N |
LL5515-3 | Exposure source | N |
LL5521-1 | Yes/No/Unk/Not Assessed | N |
LL5532-8 | Air intake type | N |
LL5533-6 | None| |
N |
LL5539-3 | none| |
N |
LL5540-1 | Entrapment | N |
LL5546-8 | Breathing pattern - cluster | N |
LL5547-6 | Bag-mask-ventilation | N |
LL555-4 | CARE_3_g02a1_Number of pressure ulcers | N |
LL5551-8 | Wound status - MIND Panel | N |
LL5552-6 | COVID19 exposures | N |
LL5598-9 | Animal exposure | N |
LL56-3 | CR_1030 | N |
LL5605-2 | Yes| |
N |
LL57-1 | CR_1040_Cancer stager | N |
LL576-0 | CARE_5_c01a_Understanding Verbal Content | N |
LL577-8 | CARE_5_c01b_Expression of Ideas/Wants | N |
LL578-6 | CARE_5_c01c_Vision | N |
LL579-4 | CARE_5_c01d_Ability to Hear | N |
LL58-9 | CR_1050_Descriptor stage | N |
LL5850-4 | Infection specification | N |
LL5862-9 | Vaccine administration location | N |
LL5905-6 | EuroSpine Morbidity state | N |
LL5909-8 | Elapsed time | N |
LL5910-6 | Blood loss | N |
LL5911-4 | Blood transfusion | N |
LL5931-2 | SARS-CoV-2 immunization status | N |
LL6117-7 | Seizure frequency | N |
LL613-1 | CR_193 | N |
LL619-8 | USSG-FHT age | N |
LL624-8 | Yes| |
N |
LL6329-8 | Schmid fall | N |
LL6350-4 | Metabolic syndrome | N |
LL66-2 | CR_1130_Peds staging coding system | N |
LL6643-2 | CVVH catheter presence | Y |
LL6669-7 | Taken medication for high blood cholesterol | N |
LL6862-8 | Age start med | N |
LL720-4 | CARE_1_C11_Race/Ethnicity | N |
LL760-0 | PhenX02_01_body weight | N |
LL761-8 | PhenX02_02_wt <9lbs at birth | N |
LL772-5 | OASIS-C_M0150 | N |
LL774-1 | OASIS-C_M0110 | N |
LL779-0 | OASIS-C_M1036 | N |
LL822-8 | OASIS-C_M2110 | N |
LL824-4 | OASIS-C_M2300 | N |
LL836-8 | Education | N |
LL866-5 | N/Yn/Ynn/U | N |
LL869-9 | AnginaLoc | N |
LL870-7 | AnginaRad | N |
LL871-5 | AnginaType | N |
LL872-3 | AnginaRelief | N |
LL873-1 | N/Y/M/U | N |
LL875-6 | DeathOnset | N |
LL879-8 | TimeCHDdeath | N |
LL890-5 | Hosp/MD | N |
LL928-3 | NAACCR_3600 | N |
LL939-0 | NAACCR_7480 | N |
LL98-5 | CR_1410_BRM treatment | N |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright